Literature DB >> 12640079

American trypanosomiasis (Chagas' disease): an unrecognised cause of stroke.

F J Carod-Artal1, A P Vargas, M Melo, T A Horan.   

Abstract

BACKGROUND: American trypanosomiasis, known as Chagas' disease (CD) is a major cause of cardiomyopathy in South America. Irreversible damage to the heart can appear 10 to 20 years after chagasic infection. The frequency of cerebrovascular complications in chronic CD is unknown.
OBJECTIVES: To describe a group of patients with chronic or latent CD affected by ischaemic stroke and identify predictive variables for stroke in CD patients. PATIENTS AND METHODS: Retrospective case series of stroke patients with CD was studied using a cross sectional, descriptive design. CD was confirmed by positive immunofluorescence and haemaglutination serology. Data were collected on age, sex, vascular risk factors, previous history of CD, diagnostic stroke subtype, electrocardiograph and echocardiography findings. Frequency of vascular risk factors were compared with a control group of 239 non-chagasic stroke patients.
RESULTS: 136 consecutive CD stroke patients, mean age 56 years, 72 women and 64 men were identified. Vascular risk factors were observed in 81.6% of CD patients. Hypertension (70.29% versus 51.47%; p=0.0004), diabetes mellitus (15.9% versus 6.61%; p=0.0143), and tobacco use (53.98% versus 30.88%; p=0.00002) were significantly less frequent in the CD stroke group. Cardiomyopathy was significantly higher in CD stroke patients (45.58% versus 24.69%; p=0.00005). Abnormal electrocardiograms was observed in 82% of chagasic patients (right bundle branch block 39.5%, left anterior fascicular block 35.8%). Left ventricle (LV) diastolic dysfunction (61.47%), LV systolic dysfunction (51.18%), congestive cardiomyopathy (29.92%), and apical aneurysm (15.74%) were the most frequent echocardiographic findings. Aetiologies were cardioembolism (52.2%), undetermined (36.76%), atherothrombotic (8.82%), and small vessel stroke (2.2%). A diagnosis of CD was established after presentation with stroke in 38.23% of the patients.
CONCLUSIONS: CD should be included in the differential diagnosis of stroke in patients of South American origin.

Entities:  

Mesh:

Year:  2003        PMID: 12640079      PMCID: PMC1738368          DOI: 10.1136/jnnp.74.4.516

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Epidemiology of concurrent Chagas disease and ischemic stroke in a population attending a multicenter quaternary rehabilitation network in Brazil.

Authors:  Vinícius Viana Abreu Montanaro; Thiago Falcão Hora; Creuza Maria da Silva; Carla Verônica de Viana Santos; Maria Inacia Ruas Lima; Eleonora Maria de Jesus Oliveira; Gabriel R de Freitas
Journal:  Neurol Sci       Date:  2019-07-30       Impact factor: 3.307

Review 2.  Overcoming research barriers in Chagas disease-designing effective implementation science.

Authors:  Andrés F Henao-Martínez; Kathryn Colborn; Gabriel Parra-Henao
Journal:  Parasitol Res       Date:  2016-10-22       Impact factor: 2.289

3.  Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice.

Authors:  Ester Roffê; Ana Paula M P Marino; Joseph Weaver; Wuzhou Wan; Fernanda F de Araújo; Victoria Hoffman; Helton C Santiago; Philip M Murphy
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

Review 4.  Neurologic manifestations of Chagas disease.

Authors:  Marco Oliveira Py
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

5.  Ischemic stroke classification and risk of embolism in patients with Chagas disease.

Authors:  Vinícius Viana Abreu Montanaro; Creuza Maria da Silva; Carla Verônica de Viana Santos; Maria Inacia Ruas Lima; Edson Marcio Negrão; Gabriel R de Freitas
Journal:  J Neurol       Date:  2016-09-13       Impact factor: 4.849

6.  Chagas disease is independently associated with brain atrophy.

Authors:  Jamary Oliveira-Filho; Rodrigo M Vieira-de-Melo; Paulo S O Reis; Amanda M Lacerda; Iuri S Neville; Carolina Cincura; Daniela F Menezes; Leila C Viana; Pedro A P Jesus; Antonio A Lopes; Francisco J F B Reis; Karen L Furie
Journal:  J Neurol       Date:  2009-04-12       Impact factor: 4.849

Review 7.  Developments in the management of Chagas cardiomyopathy.

Authors:  Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-23

8.  Causing Mechanisms of Embolic Strokes in Chagas Heart Disease: Autonomic Dysfunction, a Working Hypothesis.

Authors:  Roberto Coury Pedrosa
Journal:  Arq Bras Cardiol       Date:  2020-12       Impact factor: 2.000

9.  A morphological approach to the diagnosis of protozoal infections of the central nervous system.

Authors:  Leila Chimelli
Journal:  Patholog Res Int       Date:  2011-07-14

10.  Stroke correlates in chagasic and non-chagasic cardiomyopathies.

Authors:  José Alberto Martins da Matta; Roque Aras; Cristiano Ricardo Bastos de Macedo; Cristiano Gonçalves da Cruz; Eduardo Martins Netto
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.